Our Board of Directors
Joanne Quin, Chair
Jo holds a Bachelor of Laws with Honours from the University of Leeds, UK and a Bachelor of Arts with Honours from the University of Adelaide. She brings a broad range of skills to the table and has 10 years experience in banking and finance. Jo was also one of the founding members of the inaugural Brain Cancer Action Week launched in May 2010 at Kirribilli House. Jo is also a member of the Foundation's Finance and Risk Management Committee and the Foundation's Remuneration and Nomination's Committee.
Peter Butler, OAM
Peter is a Partner of law firm Freehills. He is Chair of the Starlight Foundation and has been president of a number of other charities. Peter was awarded a medal in the Order of Australia in 1998 for services to the community.
Beverley established The John Trivett Foundation in 1998 for brain tumour research, in memory of her late husband John Trivett. In July 2014, the John Trivett Foundation joined with Cure Brain Cancer Foundation and Beverley is now an active ambassador, benefactor and director, based in Queensland.
Tony is a Chartered Accountant with 25 years plus experience working in senior leadership roles across a number of different industries including insolvency, technology, legal services, engineering and construction. He brings a broad set of finance, operational, process, systems and business management skills. Tony joined the Board in February 2016 and is also the Chair of the Finance & Risk Management Committee.
Professor Brian Owler
Professor Owler is an adult and paediatric consultant neurosurgeon who treats both adults and children with brain cancers as well as a variety of other neurosurgical conditions. He is a consultant neurosurgeon at the Children's Hospital at Westmead, the Sydney Adventist Hospital, Norwest Private Hospital, Macquarie University Private Hospital and Westmead Private Hospital.
Morag is an experienced banker with over 15 years' experience in the Financial Services Industry encompassing the fields of finance, investment banking, balance sheet management, debt structuring/origination and digital strategy. She currently holds the position of Head of Credit Portfolio Management and Capital Advisory at Westpac Institutional Bank and is responsible for the active management of Westpac's Institutional balance sheet including capital, funding and liquidity management. Morag joined the Board in July 2016 and is also a member of the Foundation’s Finance & Risk Management Committee.
Claire is the Managing Director of Blue Seed Consulting, a boutique Change Management consultancy based in Sydney. She is a seasoned Change Management practitioner with deep experience leading and consulting on highly complex and large scale organisational transformational programs including large technology implementa tions, merger and acquisition led change, operating model redesigns and product launches. Claire joined the board in April 2016. Claire is also a member of the Foundation’s Remuneration and Nomination’s Committee.
Michael is the chairman of several private companies and Deputy CEO of EverEdge, specialising in high growth businesses and intangible assets, expanding New Zealand, the US, the UK and Australia. Michael is also Chair of the Foundation’s Remuneration and Nomination’s Committee.
Prof. Charlie Teo AM
Prof Teo was the Founder of Cure For Life, now called Cure Brain Cancer Foundation. In September 2017, Cure Brain Cancer Foundation and Professor Charlie Teo decided to pursue different strategic directions in our search for a cure for brain cancer, while both remaining deeply committed to this important cause. As such, Prof Teo and the Foundation are now completely independent from each other.
Meet the rest of the Cure Brain Cancer Foundation team